US NIH launches $215m Partnership for Accelerating Cancer Therapies
The US National Institutes of Health (NIH), along with 11 biopharmaceutical companies, has launched a $215m five-year public-private research collaboration to advance new cancer immunotherapy strategies for more patients.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Immunotherapy | National Institutes of Health (NIH) | Partnerships | Pharmaceuticals